Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Haematologica
|
October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
Oronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Life Science Alliance
|
June 30, 2021
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene
Benedetta M Santoliquido, Michela Frenquelli, Claudia Contadini, et al.
The Journal of Clinical Investigation
|
November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer
Beatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Nature Communications
|
December 30, 2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1
Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici, et al.
Cell Death & Disease
|
April 8, 2026
The deubiquitinase activity of CYLD is required for B cell differentiation
Athanasios Pseftogas, Jessica Bordini, George Gavriilidis, et al.
Scientific Reports
|
March 11, 2016
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
Rosanna Mezzapelle, Eltjona Rrapaj, Elena Gatti, et al.
Hemasphere
|
March 18, 2025
Loss of CYLD promotes splenic marginal zone lymphoma
Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, et al.
Leukemia
|
April 4, 2024
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Jessica Bordini, Chiara Lenzi, Michela Frenquelli, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Haematologica
|
October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
Oronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Life Science Alliance
|
June 30, 2021
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene
Benedetta M Santoliquido, Michela Frenquelli, Claudia Contadini, et al.
The Journal of Clinical Investigation
|
November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer
Beatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Nature Communications
|
December 30, 2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1
Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici, et al.
Cell Death & Disease
|
April 8, 2026
The deubiquitinase activity of CYLD is required for B cell differentiation
Athanasios Pseftogas, Jessica Bordini, George Gavriilidis, et al.
Scientific Reports
|
March 11, 2016
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
Rosanna Mezzapelle, Eltjona Rrapaj, Elena Gatti, et al.
Hemasphere
|
March 18, 2025
Loss of CYLD promotes splenic marginal zone lymphoma
Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, et al.
Leukemia
|
April 4, 2024
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Jessica Bordini, Chiara Lenzi, Michela Frenquelli, et al.
Page
of 2